ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

LGND Ligand Pharmaceuticals Incorporated

72.32
0.90 (1.26%)
取引時間後
最終更新日: 07:12:13
15分遅延
名称 銘柄コード 市場 種別
Ligand Pharmaceuticals Incorporated LGND NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.90 1.26% 72.32 07:12:13
始値 安値 高値 終値 前日終値
71.77 70.855 72.70 72.32 71.42
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0803:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0707:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0608:12EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0206:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0108:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:49EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
2024/2/2908:05EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2907:43EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2721:24EDGAR2Form 8-K - Current report
2024/2/1710:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1710:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1710:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1710:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1420:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1405:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1109:30GLOBEHenlius and Sermonix Announce Strategic Collaboration and..
2024/1/0607:40DJNLigand Pharmaceuticals Gets FDA OK for Viral Skin Infection..
2024/1/0506:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0705:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0705:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0122:25EDGAR2Form 8-K - Current report
2023/12/0122:20GLOBEPalvella Therapeutics and Ligand Pharmaceuticals Expand..
2023/11/2823:01GLOBESermonix Pharmaceuticals Announces Five Abstracts Accepted..
2023/11/1011:48EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/1007:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:08EDGAR2Form 8-K - Current report
2023/11/0623:00GLOBESermonix Pharmaceuticals Announces JCO Precision Oncology..
2023/10/1822:03EDGAR2Form 8-K - Current report
2023/10/1821:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
2023/10/0405:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0222:00GLOBESermonix Pharmaceuticals Shares Results of EQUALS 2 Survey..
2023/9/2721:38EDGAR2Form 8-K - Current report
2023/9/2705:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2605:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1906:26EDGAR2Form 8-K - Current report
2023/8/1505:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1005:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:02EDGAR2Form 8-K - Current report
2023/7/1721:45GLOBENovan Enters into Agreement to Sell Substantially All of its..
2023/7/1107:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1107:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2922:00GLOBESermonix Pharmaceuticals to Present Two Posters at The..
2023/6/0522:01GLOBESermonix Pharmaceuticals Shares ASCO Poster Presentation on..
2023/5/2606:00GLOBESermonix Pharmaceuticals to Share Longer Patient Follow-up..

最近閲覧した銘柄

Delayed Upgrade Clock